Literature DB >> 22271052

[Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas].

A M Schlitter1, I Esposito.   

Abstract

Intraductal papillary mucinous neoplasms (IPMN) are precursor lesions of ductal adenocarcinoma of the pancreas and one of the most common cystic entities in this organ. Branch and main duct types are further distinguished based on the tumor localization. An additional classification is based on the predominant architecture and immunohistochemical profile with four prognostic relevant subtypes, gastric, intestinal, pancreato-biliary and oncocytic. This review provides an overview about the malignant potential of the different subtypes and the prognosis of associated invasive tumors and gives recommendations for the pathological assessment of resection specimens with IPMNs.

Entities:  

Mesh:

Year:  2012        PMID: 22271052     DOI: 10.1007/s00104-011-2181-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  26 in total

1.  [New classification of pancreatic carcinoma--Japan Pancreas Society].

Authors:  Yoshifumi Kawarada
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2003-08

Review 2.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

3.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

4.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

5.  Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.

Authors:  Kieran Brune; Tadayoshi Abe; Marcia Canto; Lauren O'Malley; Alison P Klein; Anirban Maitra; N Volkan Adsay; Elliot K Fishman; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

6.  Extent of surgical resections for intraductal papillary mucinous neoplasms.

Authors:  Stefano Crippa; Stefano Partelli; Massimo Falconi
Journal:  World J Gastrointest Surg       Date:  2010-10-27

7.  Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination.

Authors:  F Paye; A Sauvanet; B Terris; P Ponsot; V Vilgrain; P Hammel; P Bernades; P Ruszniewski; J Belghiti
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

Review 8.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

9.  Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Thomas Schnelldorfer; Michael G Sarr; David M Nagorney; Lizhi Zhang; Thomas C Smyrk; Rui Qin; Suresh T Chari; Michael B Farnell
Journal:  Arch Surg       Date:  2008-07

10.  Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS.

Authors:  Daniel A Ringold; Puneet Shroff; Sanjay K Sikka; Lourdes Ylagan; Sreenivasa Jonnalagadda; Dayna S Early; Steven A Edmundowicz; Riad Azar
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

View more
  4 in total

Review 1.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 2.  [New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].

Authors:  I Esposito; B Konukiewitz; A M Schlitter; G Klöppel
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 3.  [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].

Authors:  A M Schlitter; G Klöppel; I Esposito
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 4.  Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia.

Authors:  Friederike V Opitz; Lena Haeberle; Alexandra Daum; Irene Esposito
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.